Regorafenib in metastatic colorectal cancer: An exploratory biomarker trial.

被引：0
|
作者：
Salem, Mohamed E.
Petricoin, Emanuel
Wellstein, Anton
Pierobon, Mariaelena
Wang, Hongkun
Mikhail, Sameh
Hartley, Marion L.
Smaglo, Brandon George
Lou, Emil
Alistar, Angela Tatiana
Dorsch-Vogel, Karen
Pishvaian, Michael J.
He, Aiwu Ruth
Kim, Alexander Y.
Shivapurkar, Narayan
Reddy, Sandeep K.
Marshall, John
机构：
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[2] George Mason Univ, Manassas, VA USA
[3] Ohio State Univ, James Canc Hosp, Ctr Comprehens Canc, Solove Res Inst, Columbus, OH 43210 USA
[4] Univ Minnesota, Hopkins, MN USA
[5] Wake Forest Sch Med, Winston Salem, NC USA
[6] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[7] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Med & Oncol, Washington, DC USA
[8] Georgetown Univ, Lombardi Comprehens Canc Ctr, Innovat Ctr Biomed Informat, Washington, DC USA
[9] Medstar Georgetown Univ Hosp, Intervent Radiol, Washington, DC USA
[10] Caris Life Sci, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.tps773
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS773
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    ONCOLOGY, 2017, 93 (06) : 354 - 358
  • [42] Treatment options after regorafenib failure in metastatic colorectal cancer
    Eraslan, E.
    Dogan, M.
    Yildiz, F.
    Ilhan, A.
    Oksuzoglu, O. B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (09) : 3470 - 3477
  • [43] Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer
    Goldstein, Daniel A.
    Ahmad, Bilal B.
    Chen, Qiushi
    Ayer, Turgay
    Howard, David H.
    Lipscomb, Joseph
    El-Rayes, Bassel F.
    Flowers, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Regorafenib in heavily treated metastatic colorectal cancer: Mexican experience
    Calderillo-Ruiz, German
    Torrecillas-Torres, Laura
    Silva, Alejandro
    Ruiz-Garcia, Erika
    Pimentel-Renteria, Alberto
    Hernandez-Hernandez, Carlos
    Suarez-Sahui, Tirzo
    Enriquez-Aceves, Isabel
    Campos-Gomez, Saul
    Herrera, Marytere
    Dip, Karim
    Diaz-Romero, Consuelo
    GACETA MEXICANA DE ONCOLOGIA, 2021, 20 (04): : 127 - 133
  • [45] Regorafenib for Metastatic Colorectal Cancer Common Toxicities and Prevention Strategies
    Draper, Amber
    ONCOLOGY-NEW YORK, 2019, 33 (04): : 126 - 127
  • [46] Negative hyperselection of patients with RAS wild-type metastatic colorectal cancer for panitumumab: A biomarker study of the phase III PARADIGM trial.
    Shitara, Kohei
    Muro, Kei
    Watanabe, Jun
    Yamazaki, Kentaro
    Ohori, Hisatsugu
    Shiozawa, Manabu
    Yasui, Hirofumi
    Oki, Eiji
    Sato, Takeo
    Naito, Takeshi
    Komatsu, Yoshito
    Kato, Takeshi
    Soeda, Junpei
    Yamamoto, Kouji
    Yamashita, Riu
    Akagi, Kiwamu
    Ochiai, Atsushi
    Uetake, Hiroyuki
    Tsuchihara, Katsuya
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 11 - 11
  • [47] Pharmacokinetics and pharmacodynamics relationship of regorafenib in chemorefractory metastatic colorectal cancer
    Boukerma, K.
    Vernerey, D.
    Henriques, A.
    Baumgartner, I.
    Tournigand, C.
    Andre, T.
    Hulin, A.
    Rousseau, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 17 - 17
  • [48] Regorafenib in progressive metastatic colorectal cancer (mCRC): Analysis of age subgroups in the phase III CORRECT trial
    Vogel, A.
    van Cutsem, E.
    Sobrero, A.
    Siena, S.
    Falcone, A.
    Ychou, M.
    Humblet, Y.
    Buchet, O.
    Mineur, L.
    Barone, C.
    Adenis, A.
    Tabernero, J.
    Yoshino, T.
    Lenz, H-J
    Goldberg, R. M.
    Cihon, F.
    Wagner, A.
    Grothey, A.
    ONKOLOGIE, 2013, 36 : 69 - 70
  • [49] Exploratory biomarker analysis for predicting treatment effects of aflibercept in the VELOUR trial.
    Pu, Ting
    Peddle, Allyson
    Wirapati, Pratyaksha
    Hong, Yourae
    Samuel, Leslie
    Desai, Jayesh
    Riener, Maigo
    Saridaki, Zacharenia
    Cunningham, David
    Tejpar, Sabine
    Tsantoulis, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Impact of the prior chemotherapy with two different fluoropyrimidines on the efficacy of CapeIRI or FOLFIRI in metastatic colorectal cancer: An exploratory analysis of the phase III AXEPT trial.
    Kim, Tae Won
    Muro, Kei
    Xu, Rui-hua
    Park, Young Suk
    Wang, Wei
    Han, Sae-Won
    Ota, Mitsuyoshi
    Ahn, Joong Bae
    Deng, Yanhong
    Akiyoshi, Kohei
    Cho, Sang Hee
    Ba, Yi
    Denda, Tadamichi
    Lee, Keun-Wook
    Zhang, Tao
    Matsuda, Chu
    Yamada, Yasuhide
    Morita, Satoshi
    Iwasa, Satoru
    Sakamoto, Junichi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345